Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003565:Cytidine Diphosphate / Q000378:metabolism*; D003597:Cytosine Nucleotides / Q000378:metabolism*; D004926:Escherichia coli / Q000201:enzymology; D007502:Iron Chelating Agents / Q000494:pharmacology*; D007546:Isoquinolines / Q000494:pharmacology*; D007700:Kinetics; D008114:Liver Neoplasms, Experimental / Q000378:metabolism*; D010084:Oxidation-Reduction; D012264:Ribonucleotide Reductases / Q000378:metabolism*; D013882:Thiosemicarbazones / Q000494:pharmacology*
D000970:Antineoplastic Agents; D003597:Cytosine Nucleotides; D007502:Iron Chelating Agents; D007546:Isoquinolines; D013882:Thiosemicarbazones; C013118:4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone; D003565:Cytidine Diphosphate; D012264:Ribonucleotide Reductases